MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Integra LifeSciences Holdings Corp

Deschisă

SectorSănătate

16.5 -0.9

Rezumat

Modificarea prețului

24h

Curent

Minim

16.14

Maxim

16.91

Indicatori cheie

By Trading Economics

Venit

30M

19M

Vânzări

62M

443M

P/E

Medie Sector

63.02

57.333

EPS

0.97

Marjă de profit

4.391

Angajați

4,396

EBITDA

40M

79M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+47.31% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-819M

1.2B

Deschiderea anterioară

17.4

Închiderea anterioară

16.5

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Integra LifeSciences Holdings Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 mai 2024, 16:47 UTC

Câștiguri
Principalele dinamici ale pieței

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Comparație

Modificare preț

Integra LifeSciences Holdings Corp Așteptări

Obiectiv de preț

By TipRanks

47.31% sus

Prognoză pe 12 luni

Medie 24.6 USD  47.31%

Maxim 35 USD

Minim 19 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIntegra LifeSciences Holdings Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

6 ratings

2

Cumpărare

2

Păstrare

2

Vânzare

Scor tehnic

By Trading Central

15.67 / 17.29Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Very Strong Bearish Evidence

Termen lung

Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.